0 items
CHECKOUT
 Latest News
 Quick Search
 Personal Profiles
 Current Events
 Industry News
 Managed Profiles
 Simple Search
 Advanced Search
 Recent Queries
 Companies By Industry
 Corporate Surveys
 Predecessor & Defunct
 Corporate Analyzer
 Investor Reports
 Historical Reports
 Industry Reports
 Dividends
 New Issues
 Mergers & Acquisitions
 Directory of Directors
 Additional Databases
 Person Search
 Global Search
 Lead List Generator
 Browse Radio
 Search Radio
 Browse Television
 Search Television
 Television Profiles
Company Snapshot

COMPANY INFORMATION
AEterna Zentaris Inc.
1405 boul du Parc-Technologique
Québec, QC
G1P 4P5
Tel: (418) 652-8525
Fax: (418) 652-0881

Contact Name
Ginette Vallières

Industry
Biotechnology
 

Key Executives
Jüergen Engel, CEO
Dennis Turpin, CFO

Discovers, develops and commercializes oncology and endocrine therapies to treat a variety of conditions, principally cancer. Product development pipeline includes Cetrorelix, Ozarelix and Perifosine.
FP ADVISOR COVERAGE
AEterna Zentaris Inc.
FP Corporate Analyzer
FP Directory of Directors
FP Corporate Surveys
FP Investor Reports
FP Predecessor & Defunct
Ordering FP Products
 
TOP INDUSTRY PLAYERS
Biotechnology
Company NameRevenue ($000s) 
Atrium Innovations Inc. 309,546
Angiotech Pharmaceuticals, Inc. 302,251
QLT Inc. 132,457
Oncothyreon Inc. 42,678
AEterna Zentaris Inc. 41,056
(Links are to Snapshots.)
 
FINANCIAL RATIOS AS OF FEB 8/10
Listed Close 52-wk
High
52-wk
Low
IAD Latest
Dividend
Yield 60-mo
Beta
TSX/AEZ
Nasdaq/AEZS
$0.88 $3.49 $0.72 n.a. n.a. n.a. 1.36
Avg 20-day
Volume
P/E 12-mo
EPS
EPS
Date
1-yr
Return
3-yr
Return
5-yr
Return
Market
Cap. (000s)
101,606 n.a. US$-0.94 Sept. 30/09 -16.19% -42.99% -27.21% $55,519
 
ANNUAL FINANCIALS
Periods ended: 12m Dec. 31/08 12m Dec. 31/07 12m Dec. 31/06
US$000s US$000s US$000s
Operating revenue 38,478 42,068 41,392
Net income (59,817) (32,296) 33,390
Total assets 108,342 123,363 223,491
US$ US$ US$
Earnings per share* (1.12) (0.61) 0.64
% % %
Return on equity (108.69) (23.96) 5.06
 
* Common
 
TRAILING 12-MONTH VALUES
Periods ended: Sept. 30/09 Sept. 30/08
US$000s US$000s
Operating revenue 30,299 39,531
Net income (51,249) (58,960)
US$ US$
Earnings per share (0.93) (1.11)
 

COMPANY NEWS
Results for 'AEterna Zentaris Inc.' from past 30 days:
No hits.


(Links are to articles.)


© 2006-2010 Canwest Digital Media, a division of Canwest Publishing Inc. All Rights Reserved. Copyright | Terms Of Use | Privacy Statement